Research & Development: Page 82

PharmaVoice Team/PharmaVoice

Bio Meets Pharma to Form the New Age of Biopharma

By Denise Myshko In the future, broad-based companies will choose the most appropriate approach, whether small molecule or biologic, to create new interventions. The distinction between biotech and pharma is blurring. The result: broad-based companies use their expertise in a disease and the unde...
By Denise Myshko • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Table of Contents

A.J. Kazimi says public perception is one obstacle midsize companies face. Jill Balderson says patients need more information about diseases. Dr. Dahiyat’s technology could change the face of medicine. October 2006 PharmaVOICE On the Cover Midsize pharma: Moving and shaking the industry Unlike th...
By PharmaVoice Team • Jan. 2, 2008
Explore the Trendline➔

Stock via Getty Images

Trendline

Clinical trial diversity

As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff
PharmaVoice Team/PharmaVoice

Letter from the Editor

October is National Breast Cancer Awareness Month. We at PharmaVOICE thought it appropriate, therefore, to focus this month’s therapeutic specialty on this important area of research and treatment. According to the American Cancer Society, breast cancer death rates are going down. The chance of d...
By Taren Grom • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

E-Media

New Electronic and Web-based Applications, Sites, and Technologies InfoMedics’ Treatment Educator Improves Patient Understanding and Increases Brand Loyalty InfoMedics Inc. has released Treatment Educator, a tool for improving prescription compliance through patient education and treatment unders...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

On the Calendar

Your Source for Life-Sciences Events and Conference Information Professional education is an ongoing endeavor for most executives. PharmaVOICE has partnerships with every major conference provider serving the life-sciences industry. PharmaVOICE is distributed at more than 150 industry events a ye...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

What's New

New Healthcare-related Products, Services, and Companies Scientific Advantage Launches MSL Outsourcing Subsidiary The new division addresses client requests for MSL professionals. Scientific Advantage LLC has formed MSL Advantage LLC to fill MSL staffing positions within pharmaceutical, biotech, ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

The Discovery Bug -- Dr. Graham Allaway

By Kim Ribbink Graham Allaway, Ph.D. Whether Dr. Allaway is exploring the open seas in his single-handed Laser or investigating uncharted areas in virology, he attends to both with equal passion, commitment, and focus. In small companies, people are pulling in the same direction; it’s truly a tea...
By Kim Ribbink • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

IRBs The Safety Gatekeepers

By Denise Myshko Current pressures to speed drugs to market have resulted in the increased use of independent, centralized institutional review boards as an alternative to academic IRBs, because they can offer faster and more efficient protocol reviews. Institutional review boards, or IRBs, are a...
By Denise Myshko • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Pharma Has The Data But Not The Information

Michael Rosenberg, M.D., MPH, President and CEO of Health Decisions Inc., Chapel Hill, N.C., discusses why, compared with other large industries, pharma’s automation processes lag behind. Are you involved with clinical research? If so, take a moment to imagine what if every clinical research assi...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

PharmaTrax

Nanotech Sector Continues Strong Growth Sales, Marketing, and R&D Trends from Industry Analysts The commercialization of nanotechnology continues to gain momentum worldwide, according to The Nanotech Report, 4th Edition, a comprehensive and up-to-date reference study on nanotechnology, releas...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

DIA 2006 -- Annual Conference

DIA 2006 — Breaks Attendance Records September 2006 Sanjay Gupta, M.D., senior medical correspondent for the health and medical unit at CNN, practicing neurosurgeon, and an assistant professor of neurosurgery gave the keynote speech at the 42nd Annual DIA Meeting. The conference drew record numbe...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Global Perspective

Staffing Multinational Trials A Time for Creative Solutions In the past decade, an unprecedented push to field Global clinical trials has boosted the demand for patients and CRAs from Asia to Zambia. Sponsors expect rock-bottom pricing, transparency, local staff with a breadth of experience, and ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

UpFront

Consumers Talk Back Countering DTC Criticism Challenging many of the assumptions of both academic and public-policy critics of DTC, CommonHealth filed a research report with the FDA based on analysis of 440 transcripts of actual provider-patient interactions in community-practice settings recorde...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Cover

A Team Approach Breaking Down the Silos Debugging the Pipeline with Graham Allaway, Ph.D. Name that Brand Clinical Gatekeepers: Institutional Review Boards The Forum for the Industry Executive September 2006 Volume 6 Number 8 Download PDF
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Letter from the Editor

Ben Franklin and Taren Grom at the MediciGroup booth at the 42nd Annual Drug Information Association meeting in Philadelphia. An innovative approach Many consider Ben Franklin to be one of America’s most prolific inventors. Throughout his colorful life, Ben Franklin pursued scientific knowledge w...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Integrating Outcomes Studies Into Medical Education

August 2006 VIEW on Medical Education Outcomes measurement Integrating Outcomes Studies Into Medical Education CME LLC, Irvine, Calif., is dedicated to providing high-quality, life-long learning opportunities for clinicians through a variety of convenient learning formats. For more infor...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Solutions to Bridging the Cross-Cultural Divide in Healthcare

Solutions to Bridging the Cross-Cultural Divide in Healthcare Program Development Sudler & Hennessey AnneMarie Armani, M.D. Senior Medical Director, Imprint Science Daria Blackwell Consultant, Sudler Multicultural Education Ruben Gutierrez Director, Sudler Multicultural Education ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Why Physicians Learn

Why Physicians Learn Program Development David St. Peter, M.D., Executive VP/Managing Director Customer insights, such as having unique perspectives into what motivates an audience to learn, are critical to the development of successful programs that effectively change behavior. Some may s...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Building a Successful Partnership Between Medical Education Companies and Recruitment Vendors

Building a Successful Partnership Between Medical Education Companies and Recruitment Vendors Partnerships Judy Hagan General Manager and Senior VP of Sales and Marketing Having weathered the changing landscape of CME, it has become abundantly clear that MECs c...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Measuring Educational Outcomes in CME

August 2006 VIEW on Medical Education Postgraduate Institute for Medicine Outcomes measurement Measuring Educational Outcomes in CME Jan Schultz, RN, MSN Director, Educational Outcomes and Accreditation Michael R. Lemon, MBA President Commercial supporters want their grant dollar...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Making the Ordinary Satellite Symposium Extraordinary

Making the Ordinary Satellite Symposium Extraordinary Fission Communications Event Planning Mario R. Nacinovich Jr. Senior VP, Chief Creative Officer James A. Karcher Senior Director, Strategic Planning and Business Development Richard L. Abbot Jr. Group Business Director Th...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

The Researchers & Scientists

Dr. Daniel P. Getman A Scientific Home Run A leading scientist and a respected spokesperson, Daniel Getman, Ph.D., is a strong advocate for the value of pharmaceutical innovation. His extensive insight into medicinal chemistry has made Dr. Getman, VP of global research and development, director, ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

The Technologists

These technology leaders are taking computer-based and enabled solutions to the next plateau and in doing so they are reducing the time needed to conduct clinical trials, cutting the cost of clinical development, and ensuring that the products that do make it to market are properly evaluated for ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

The Mentors

The Mentors These outstanding individuals unselfishly give of their time and provide their insights to mentor the next generation of business leaders. July/August 2006 PharmaVOICE 100 Kathleen Case Paddling in One Direction For Kathleen Case, directing a group of 23 professionals as her first for...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Cover

100 of the most inspiring people July/August 2006 PharmaVOICE pharmavoice.com Volume 6 Number 7 Download PDF
By PharmaVoice Team • Jan. 2, 2008